Stockreport

AVEO Oncology: A High Risk, High Reward Play [Seeking Alpha]

Bristol-Myers Squibb Company  (BMY) 
Last bristol-myers squibb company earnings: 2/6 07:05 am Check Earnings Report
US:NYSE Investor Relations: bms.com/investors.html
PDF Summary Introduction AVEO Oncology ( AVEO ) is a small cap biotechnology company focused in developing its lead product tivozanib (Fotivda ® ), an oral inhibit [Read more]